1. Home
  2. AIRE vs MURA Comparison

AIRE vs MURA Comparison

Compare AIRE & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

N/A

Current Price

$0.44

Market Cap

40.7M

Sector

N/A

ML Signal

N/A

Logo Mural Oncology plc

MURA

Mural Oncology plc

HOLD

Current Price

$2.04

Market Cap

36.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
MURA
Founded
2021
2013
Country
United States
Ireland
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
40.7M
36.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIRE
MURA
Price
$0.44
$2.04
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$2.00
$6.00
AVG Volume (30 Days)
3.6M
224.8K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,149,567.00
N/A
Revenue This Year
$411.48
N/A
Revenue Next Year
$141.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
994.18
N/A
52 Week Low
$0.14
$0.95
52 Week High
$4.49
$4.74

Technical Indicators

Market Signals
Indicator
AIRE
MURA
Relative Strength Index (RSI) 39.80 40.40
Support Level $0.51 $2.06
Resistance Level $0.53 $2.10
Average True Range (ATR) 0.04 0.01
MACD -0.00 -0.01
Stochastic Oscillator 2.60 25.00

Price Performance

Historical Comparison
AIRE
MURA

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: